Fukagawa M - Search Results

1

Comparison of paricalcitol with maxacalcitol injection in Japanese hemodialysis patients with secondary hyperparathyroidism.

Akizawa T, Akiba T, Hirakata H, Kinugasa E, Tominaga Y, Fukagawa M, Yokoyama K, Zhang W, Linde PG, Suzuki M. Akizawa T, et al. Among authors: fukagawa m. Ther Apher Dial. 2015 Jun;19(3):225-34. doi: 10.1111/1744-9987.12242. Epub 2014 Nov 3. Ther Apher Dial. 2015. PMID: 25363733 Clinical Trial.

2

The negative Ca(2+) balance is involved in the stimulation of PTH secretion.

Yokoyama K, Kagami S, Ohkido I, Kato N, Yamamoto H, Shigematsu T, Nakayama M, Fukagawa M, Kawaguchi Y, Hosoya T. Yokoyama K, et al. Among authors: fukagawa m. Nephron. 2002 Sep;92(1):86-90. doi: 10.1159/000064484. Nephron. 2002. PMID: 12187089

3

Guidelines for percutaneous ethanol injection therapy of the parathyroid glands in chronic dialysis patients.

Fukagawa M, Kitaoka M, Tominaga Y, Akizawa T, Kakuta T, Onoda N, Koiwa F, Yumita S, Kurokawa K; Japanese Society for Parathyroid Intervention. Fukagawa M, et al. Nephrol Dial Transplant. 2003 Jun;18 Suppl 3:iii31-3. doi: 10.1093/ndt/gfg1008. Nephrol Dial Transplant. 2003. PMID: 12771296

4

IRMA (whole PTH) is a more useful assay for the effect of PTH on bone than the Allegro intact PTH assay in CAPD patients with low bone turnover marker.

Tanno Y, Yokoyama K, Nakayama M, Katoh A, Yamamoto H, Iwasaki Y, Cantor T, Fukagawa M, Shigematsu T, Hosoya T. Tanno Y, et al. Among authors: fukagawa m. Nephrol Dial Transplant. 2003 Jun;18 Suppl 3:iii97-8. doi: 10.1093/ndt/gfg1025. Nephrol Dial Transplant. 2003. PMID: 12771313

5

Extracorporeal albumin dialysis.

Abe T, Shono M, Kodama T, Kita Y, Fukagawa M, Akizawa T. Abe T, et al. Among authors: fukagawa m. Ther Apher Dial. 2004 Jun;8(3):217-22. doi: 10.1111/j.1526-0968.2004.00148.x. Ther Apher Dial. 2004. PMID: 15154874

6

Total parathyroidectomy reduces elevated circulating fibroblast growth factor 23 in advanced secondary hyperparathyroidism.

Sato T, Tominaga Y, Ueki T, Goto N, Matsuoka S, Katayama A, Haba T, Uchida K, Nakanishi S, Kazama JJ, Gejyo F, Yamashita T, Fukagawa M. Sato T, et al. Among authors: fukagawa m. Am J Kidney Dis. 2004 Sep;44(3):481-7. Am J Kidney Dis. 2004. PMID: 15332221

7

Bio-intact parathyroid hormone and intact parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism receiving intravenous calcitriol therapy.

Fujimori A, Sakai M, Yoshiya K, Shin J, Kim JI, Inaba Y, Miyamoto T, Inoue S, Fukagawa M. Fujimori A, et al. Among authors: fukagawa m. Ther Apher Dial. 2004 Dec;8(6):474-9. doi: 10.1111/j.1774-9987.2004.00189.x. Ther Apher Dial. 2004. PMID: 15663547

8

How to apply and adapt international guidelines on bone metabolism and disease to the management of Japanese dialysis patients.

Fukagawa M, Akizawa T. Fukagawa M, et al. Ther Apher Dial. 2005 Feb;9(1):1-2. doi: 10.1111/j.1774-9987.2005.00204.x. Ther Apher Dial. 2005. PMID: 15828896 No abstract available.

9

Control of parathyroid function in patients with a short history of hemodialysis.

Nishi H, Sato T, Kurihara T, Kurosawa T, Fukagawa M. Nishi H, et al. Among authors: fukagawa m. Ther Apher Dial. 2005 Feb;9(1):39-43. doi: 10.1111/j.1774-9987.2005.00212.x. Ther Apher Dial. 2005. PMID: 15828904 Clinical Trial.

10

Efficacy of percutaneous ethanol injection therapy for secondary hyperparathyroidism in patients on hemodialysis as evaluated by parathyroid hormone levels according to K/DOQI guidelines.

Tanaka M, Itoh K, Matsushita K, Matsushita K, Fukagawa M. Tanaka M, et al. Among authors: fukagawa m. Ther Apher Dial. 2005 Feb;9(1):48-52. doi: 10.1111/j.1774-9987.2005.00214.x. Ther Apher Dial. 2005. PMID: 15828906

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

620 results

Search Page

Filters